Funds holding Allogene Therapeutics Inc
ISIN US0197701065 · United States
- Fund holders
- 141
- Of which ETFs
- 22 119 other funds
- Value held
- 120.5M $
- Share of capital
- 14.4 % of 345.5M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS | 5,364,570 | 13.1M $ | 0.05 % | 1.55 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 5,212,606 | 12.7M $ | 0.17 % | 1.51 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,879,191 | 11.9M $ | 0.00 % | 1.41 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 3,834,951 | 9.4M $ | 0.01 % | 1.11 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 3,830,998 | 9.3M $ | 0.09 % | 1.11 % | as of Mar 31, 2026 ↗ |
| PRIMECAP Odyssey Aggressive Growth Fund PRIMECAP Odyssey Funds | 3,375,270 | 7.2M $ | 0.11 % | 0.98 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,881,862 | 4.6M $ | 0.01 % | 0.54 % | as of Mar 31, 2026 ↗ |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 1,565,200 | 3.3M $ | 0.09 % | 0.45 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1,544,912 | 3.3M $ | 0.01 % | 0.45 % | as of Apr 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 1,401,115 | 3.9M $ | 0.07 % | 0.41 % | as of Feb 28, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 1,358,691 | 3.3M $ | 0.03 % | 0.39 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 1,208,862 | 3.4M $ | 0.05 % | 0.35 % | as of Feb 27, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,145,572 | 2.8M $ | 0.03 % | 0.33 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 989,626 | 2.4M $ | 0.00 % | 0.29 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 876,401 | 1.9M $ | 0.01 % | 0.25 % | as of Apr 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 868,066 | 2.4M $ | 0.01 % | 0.25 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 788,071 | 2.2M $ | 0.01 % | 0.23 % | as of Feb 28, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 764,057 | 2.1M $ | 0.01 % | 0.22 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 553,583 | 1.2M $ | 0.04 % | 0.16 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 452,327 | 1.3M $ | 0.01 % | 0.13 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 345,524 | 843.1K $ | 0.00 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 340,989 | 726.3K $ | 0.01 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 325,681 | 905.4K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 313,179 | 764.2K $ | 0.07 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 303,899 | 647.3K $ | 0.12 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 262,695 | 641K $ | 0.01 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 250,000 | 610K $ | 0.50 % | 0.07 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 243,268 | 593.6K $ | 0.09 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 241,276 | 513.9K $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 233,054 | 647.9K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| SMALL CAP EQUITY FUND GuideStone Funds | 213,000 | 519.7K $ | 0.06 % | 0.06 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 205,690 | 438.1K $ | 0.01 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust | 193,944 | 473.2K $ | 0.03 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 182,788 | 389.3K $ | 1.04 % | 0.05 % | as of Apr 30, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 175,020 | 427K $ | 0.01 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 170,147 | 362.4K $ | 0.01 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 167,572 | 465.9K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 148,999 | 317.4K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 146,779 | 358.1K $ | 0.05 % | 0.04 % | as of Mar 31, 2026 ↗ |
| NVIT Multi-Manager Small Company Fund Nationwide Variable Insurance Trust | 140,450 | 342.7K $ | 0.10 % | 0.04 % | as of Mar 31, 2026 ↗ |
| EQ/Small Company Index Portfolio EQ Advisors Trust | 140,441 | 342.7K $ | 0.02 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 134,268 | 327.6K $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 132,049 | 367.1K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 131,123 | 279.3K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 125,876 | 307.1K $ | 0.14 % | 0.04 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 121,000 | 295.2K $ | 0.16 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 111,827 | 310.9K $ | 0.03 % | 0.03 % | as of Feb 28, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 94,053 | 200.3K $ | 0.11 % | 0.03 % | as of Apr 30, 2026 ↗ |
| LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 93,800 | 228.9K $ | 0.01 % | 0.03 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 92,282 | 225.2K $ | 0.14 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 89,181 | 217.6K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 85,855 | 182.9K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 84,135 | 205.3K $ | 0.07 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Fund Northern Funds | 77,171 | 188.3K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 73,377 | 179K $ | 0.05 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 72,032 | 175.8K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 69,884 | 170.5K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Global X Russell 2000 ETF GLOBAL X FUNDS | 67,749 | 144.3K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 65,327 | 159.4K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 63,774 | 135.8K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 62,314 | 173.2K $ | 0.01 % | 0.02 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 59,456 | 126.6K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 51,531 | 125.7K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 50,661 | 107.9K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II | 50,340 | 122.8K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 47,400 | 115.7K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 46,472 | 99K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 45,405 | 126.2K $ | 0.90 % | 0.01 % | as of Feb 28, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 42,477 | 103.6K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 40,443 | 98.7K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small-Cap Index Portfolio PACIFIC SELECT FUND | 37,547 | 91.6K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| ATM Small Cap Managed Volatility Portfolio EQ Advisors Trust | 34,397 | 83.9K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AVIP BlackRock Advantage Small Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 31,927 | 77.9K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Index Fund Nationwide Variable Insurance Trust | 29,700 | 72.5K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 29,017 | 70.8K $ | 0.17 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Index Trust John Hancock Variable Insurance Trust | 28,391 | 69.3K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 25,145 | 61.4K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 24,824 | 52.9K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 24,600 | 60K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| NVIT GS Small Cap Equity Insights Fund Nationwide Variable Insurance Trust | 24,042 | 58.7K $ | 0.03 % | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 23,989 | 58.5K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Russell Small/Mid-Cap Index Fund BlackRock Funds | 21,990 | 46.8K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| DWS Small Cap Index VIP DEUTSCHE DWS INVESTMENTS VIT FUNDS | 21,656 | 52.8K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Small Cap Equity Fund TIAA-CREF Life Funds | 21,470 | 52.4K $ | 0.07 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 21,160 | 45.1K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| BlackRock Small Cap Index V.I. Fund BlackRock Variable Series Funds, Inc. | 21,031 | 51.3K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 20,200 | 56.2K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Small-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 19,660 | 48K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 18,772 | 45.8K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 18,568 | 45.3K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 17,582 | 42.9K $ | 0.24 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 17,119 | 36.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Small Cap Index Portfolio SUNAMERICA SERIES TRUST | 16,899 | 36K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Voya RussellTM Small Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 16,156 | 39.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 13,886 | 33.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 13,332 | 32.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 13,271 | 32.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 13,004 | 31.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 12,559 | 30.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 12,556 | 34.9K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| WisdomTree BioRevolution Fund WisdomTree Trust | 1.25 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.04 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.90 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.50 % | as of Mar 31, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 0.24 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.17 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.17 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 0.16 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.14 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.14 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 141 | +17 | 49,773,957 | +37.8 % |
| 2026Q1 | 124 | -9 | 36,111,122 | -1.3 % |
| 2025Q4 | 133 | +5 | 36,572,295 | -21.2 % |
| 2025Q3 | 128 | -25 | 46,388,929 | -15.9 % |
| 2025Q2 | 153 | -13 | 55,166,838 | -14.2 % |
| 2025Q1 | 166 | -10 | 64,329,116 | -7.3 % |
| 2024Q4 | 176 | -12 | 69,369,234 | -7.2 % |
| 2024Q3 | 188 | -17 | 74,724,305 | +21.0 % |
| 2024Q2 | 205 | +12 | 61,745,454 | +15.9 % |
| 2024Q1 | 193 | -5 | 53,297,706 | -10.6 % |
| 2023Q4 | 198 | 59,598,564 |
Institutional managers
202 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Pfizer Inc | 22,032,040 | 49.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 19,091,095 | 46.6M $ | as of Mar 31, 2026 |
| TPG GP A, LLC | 18,716,306 | 45.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 8,660,306 | 21.1M $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 8,379,840 | 20.4M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 6,793,620 | 16.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5,380,902 | 13.1K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 5,375,456 | 13.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,124,178 | 10.1M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 3,796,668 | 9.3M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 3,501,078 | 8.5M $ | as of Mar 31, 2026 |
| Patient Square Capital LP | 3,450,000 | 8.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 3,447,984 | 8.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,322,053 | 8.1M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 2,997,318 | 7.3M $ | as of Mar 31, 2026 |
| Wildcat Capital Management, LLC | 2,920,787 | 7.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,766,244 | 6.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,763,776 | 6.7M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 2,725,000 | 6.6M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 2,484,780 | 6.1M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,315,092 | 5.6M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 2,242,933 | 5.5M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,139,328 | 5.2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,134,473 | 5.2M $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,013,508 | 4.9M $ | as of Mar 31, 2026 |
Declared shareholders of Allogene Therapeutics Inc
There are 5 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Arie Belldegrun, M.D. and 5 others | 5.40 % | 13,466,383 | as of Mar 31, 2026 · SCHEDULE 13G |
| David D. Chang, M.D., Ph.D. and 3 others | 4.90 % | 12,297,354 | as of Mar 31, 2026 · SCHEDULE 13G |
| Frazier Life Sciences Public Fund, L.P. and 13 others | 4.70 % | 16,205,306 | as of Apr 16, 2026 · SCHEDULE 13G |
| Citadel Advisors LLC and 6 others | 2.80 % | 6,855,120 | as of Mar 31, 2026 · SCHEDULE 13G |
| Lynx1 Capital Management LP and 1 other | 0.00 % | 0 | as of Dec 31, 2025 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Allogene Therapeutics Inc". https://titelia.com/en/stocks/allogene-therapeutics-inc-US0197701065